top of page


Genpax Partners with IQVIA to Advance Genomics Solutions for AMR and Infectious Diseases
1st October 2024, London  – Genpax, a leader in pathogen genomics, is proud to announce a strategic partnership with IQVIA, a global provider of advanced health analytics, technology solutions, and clinical research services. Together, the two organizations aim to accelerate the fight against antimicrobial resistance (AMR) and other infectious diseases by leveraging cutting-edge genomics and data analytics solutions. Through this collaboration, Genpax will provide cutting-edg
Sep 30, 20242 min read


Genpax Poster: Limitations of sequence typing for isolate inclusion in outbreak investigationsÂ
Presented by Karolina Jackowska at the ESCMID Global Conference in Barcelona, 2024 Download the High Resolution PDF below:
Jun 10, 20241 min read


Genpax named 2023 winners of the IET Excellence and Innovation Award for Health Technology
Genpax, a life science startup focused on transforming healthcare in detecting, tracing, and mitigating the spread of bacterial pathogens, has been announced as a winner by the IET for their 2023 Excellence and Innovation Awards. The Awards celebrate the most pioneering engineering and technology innovations across 16 sectors, from energy and sustainability to manufacturing and healthcare. Chosen by a panel of expert judges, Genpax won the Health Technology award for their re
Nov 30, 20232 min read
bottom of page
